J-Holdings Corp. (TYO:2721)
105.00
0.00 (0.00%)
Sep 9, 2026, 3:30 PM JST
J-Holdings Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 282 | 189 | 179 | 175 | 111 | 116 |
Revenue Growth | 83.12% | 5.59% | 2.29% | 57.66% | -4.31% | -90.51% |
Gross Profit Gross Profit Growth | 174 | 111 | 101 | 101 | 41 | 47 |
Operating Income Operating Income Growth | -278 | -311 | -267 | -280 | -201 | -129 |
Net Income Net Income Growth | -222 | -256 | -387 | -296 | -270 | -150 |
Earnings Per Share EPS Growth | -22.45 | -29.63 | -55.28 | -44.69 | -54.10 | -34.61 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Environmental Solution Business Environmental Solution Business Growth | 129.2 | 69.52 | 64.7 | 64.42 | - | - |
Sports business Sports business Growth | 111.66 | 114.09 | 114.88 | 111.01 | 109.82 | 109.28 |
Regenerative Medicine Related Business Regenerative Medicine Related Business Growth | - | 6 | - | - | - | - |
Total Total Growth | 282.86 | 189.61 | 179.57 | 175.43 | 111.82 | 116.2 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 396 | 93 | 53 | 23 | 124 | 85 |
Total Debt Total Debt Growth | - | - | 70 | - | - | - |
Net Cash (Debt) Net Cash Growth | 396 | 93 | -17 | 23 | 124 | 85 |
Net Cash Growth | 144.44% | - | - | -81.45% | 45.88% | -50.00% |
Net Cash Per Share Net Cash Per Share Growth | 40.04 | 10.76 | -2.43 | 3.47 | 24.85 | 19.61 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -269 | -357 | -219 | -198 | -144 | -85 |
Capital Expenditures CapEx Growth | -45 | -171 | - | -6 | -19 | -5 |
Free Cash Flow Free Cash Flow Growth | -314 | -528 | -219 | -204 | -163 | -90 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 61.70% | 58.73% | 56.43% | 57.71% | 36.94% | 40.52% |
Operating Margin | -98.58% | -164.55% | -149.16% | -160.00% | -181.08% | -111.21% |
Pretax Margin | -77.30% | -133.33% | -214.53% | -168.00% | -240.54% | -128.45% |
Profit Margin | -78.72% | -135.45% | -216.20% | -169.14% | -243.24% | -129.31% |
FCF Margin | -111.35% | -279.37% | -122.35% | -116.57% | -146.85% | -77.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 6.15 | 9.48 | 6.21 | 8.84 | 15.94 | 7.10 |